U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plant
The findings, issued after the FDA inspected the company’s factory in Dadra and Nagar Haveli in January, said some units in the facility posed risks of microbiological contamination
The findings, issued after the FDA inspected the company’s factory in Dadra and Nagar Haveli in January, said some units in the facility posed risks of microbiological contamination
What's Your Reaction?
